Swedish Cancer Society grants over SEK 40 million to CMB researchers

We congratulate the eleven researchers at the Department of Cell and Molecular Biology who have been awarded grants from the Swedish Cancer Society (Cancerfonden) for the period 2025-2027. Together, the CMB researchers are awarded grants of over SEK 40 million.
Laura Baranello
Title: How MYC drives transcriptional amplification via regulation of DNA topology.
Amount granted for 2025-2027: SEK 3 750 000.
Nico Dantuma
Title: Targeting the ubiquitin-proteasome system in cancer.
Amount granted for 2025-2027: SEK 5 250 000.
Maria Genander
Title: Uncovering regionalized mechanisms of epithelial progenitor cell behaviors.
Amount granted for 2025-2027: SEK 3 000 000.
Jean Hausser
Title: Interpreting tumor single-cell and spatial transcriptomics in terms of micro-environmental drivers of tumor growth to target in therapy.
Amount granted for 2025-2027: SEK 3 000 000.
Martin Hällberg
Title: Structural Biology of HSV Replication: Paving the Way for Novel Antiviral Therapies and Cancer Treatment Strategies.
Amount granted for 2025-2027: SEK 3 000 000.
Randall Johnson
Title: Oxygen metabolism, T cell function, and immunotherapeutic efficacy.
Amount granted for 2025-2027: SEK 5 250 000.
Maria Kasper
Title: Cellular heterogeneity and microenvironmental control of skin cancer.
Amount granted for 2025-2027: SEK 4 500 000.
Arne Lindqvist
Title: A novel route to the formation of giant polyploid cells.
Amount granted for 2025-2027: SEK 2 000 000.
Maria G. Masucci
Title: Mechanism of translation reprogramming and interference with ribosomal and integrated stress responses in viral oncogenesis.
Amount granted for 2025-2027: SEK 6 000 000.
Jonas Muhr
Title: Targeting of Glioblastoma Stem Cells Maintaining Mechanisms.
Amount granted for 2025-2027: SEK 2 000 000.
Federico Pietrocola
Title: Harnessing the immunogenic potential of senescence for cancer prevention and therapy.
Amount granted for 2025-2027: SEK 3 000 000.